Bisphosphonates for osteoporosis in people with cystic fibrosis.

  title={Bisphosphonates for osteoporosis in people with cystic fibrosis.},
  author={Louise S Conwell and Anne B Chang},
  journal={The Cochrane database of systematic reviews},
BACKGROUND Osteoporosis is a bone mineralisation disorder occurring in about one third of adults with cystic fibrosis. Bisphosphonates can increase bone mineral density and decrease the risk of new fractures in post-menopausal women and people receiving long-term oral corticosteroids. OBJECTIVES To assess the effects of bisphosphonates on the frequency of fractures, bone mineral density, quality of life, adverse events, trial withdrawals, and survival in people with cystic fibrosis. SEARCH… CONTINUE READING